| 注册
首页|期刊导航|局解手术学杂志|环状RNA参与卵巢癌铂耐药相关机制的研究进展

环状RNA参与卵巢癌铂耐药相关机制的研究进展

刘彬馨 范雅丹 吕春燕 梅子曼 邓青春

局解手术学杂志2024,Vol.33Issue(2):179-182,4.
局解手术学杂志2024,Vol.33Issue(2):179-182,4.DOI:10.11659/jjssx.07E023007

环状RNA参与卵巢癌铂耐药相关机制的研究进展

Research progress on the mechanism of circular RNA involved in platinum resistance in ovarian cancer

刘彬馨 1范雅丹 1吕春燕 1梅子曼 1邓青春1

作者信息

  • 1. 海南医学院第二附属医院妇科,海南 海口 570100
  • 折叠

摘要

Abstract

Ovarian cancer has become the most lethal gynecological tumor due to the difficulty in early diagnosis,the late stage when diagnosed and the high recurrence rate.Resistance to platinum-based anti-tumor chemotherapy drugs is an important reason for the poor prognosis of ovarian cancer.circular RNA(circRNA)is more stable than mRNA in cells due to its special structure,and it is involved in the regulation of the occurrence,development and chemotherapy resistance of a variety of tumors.circRNA can be used as a competing endogenous RNA(ceRNA)of miRNA to bind to proteins,and regulates the phenotypic polarization of macrophages,it can also be used as an exosomal circRNA to regulate the sensitivity of platinum resistance in ovarian cancer.circRNA is expected to be a new marker of platinum resistance and a new target for the treatment of platinum resistance.In order to further explore the relationship between circRNA and platinum resistance in ovarian cancer,this article summarizes the recent literature related to circRNA and platinum resistance in ovarian cancer.

关键词

环状RNA/卵巢癌/铂耐药/机制/综述

Key words

circular RNA/ovarian cancer/platinum resistance/mechanism/review

分类

临床医学

引用本文复制引用

刘彬馨,范雅丹,吕春燕,梅子曼,邓青春..环状RNA参与卵巢癌铂耐药相关机制的研究进展[J].局解手术学杂志,2024,33(2):179-182,4.

基金项目

2021年海南省自然科学基金高层次人才项目(821RC712) (821RC712)

2022年海南省重点研发计划项目(ZDYF2022SHFZ068) (ZDYF2022SHFZ068)

局解手术学杂志

OACSTPCD

1672-5042

访问量0
|
下载量0
段落导航相关论文